Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLOMAX in Female Patients With LUTS
NCT02244281Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 2001
- Primary completion
- Nov 2003
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of tamsulosin in lower urinary tract symptoms (LUTS), sponsored by Boehringer Ingelheim. Started May 2001; status: completed.
02
Drugs
tamsulosin
03
Conditions
lower urinary tract symptoms (LUTS)
Beyond the preview
Go deeper on NCT02244281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02244281.